Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
Christina Fotiadou, Efstratios Vakirlis, Dimitrios Ioannides First Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, Greece Abstract: Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease that affects the hair folli...
Saved in:
Main Authors: | Fotiadou C (Author), Vakirlis E (Author), Ioannides D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adalimumab in the treatment of moderate-severe hidradenitis suppurativa: a cost-effectiveness analysis
by: Sofia Borges, et al.
Published: (2018) -
Adalimumab effect on pain in hidradenitis suppurativa patients: systematic review and meta-analysis
by: Aikaterini Tsentemeidou, et al.
Published: (2022) -
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
by: Aikaterini Kyriakou, et al.
Published: (2018) -
Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab
by: Ian Gorovoy, et al.
Published: (2009) -
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
by: Elisa Molinelli, et al.
Published: (2022)